![Toujeo 300 units/ml SoloStar, solution for injection in a pre-filled pen - Summary of Product Characteristics (SmPC) - (emc) Toujeo 300 units/ml SoloStar, solution for injection in a pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)](https://www.medicines.org.uk/emc/images/spc/spc~30586~12~image1.png)
Toujeo 300 units/ml SoloStar, solution for injection in a pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)
![Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements - Scott M. Pearson, Jennifer M. Trujillo, 2018 Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements - Scott M. Pearson, Jennifer M. Trujillo, 2018](https://journals.sagepub.com/cms/10.1177/2042018818760962/asset/images/large/10.1177_2042018818760962-fig1.jpeg)
Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements - Scott M. Pearson, Jennifer M. Trujillo, 2018
![Impact of Dosing Conversion From Basal Insulin to Follow-On Insulin Glargine - Marina L. Maes, Emily J. Ashjian, Kellie A. Kippes, Vince Marshall, Nada Rida, Amy N. Thompson, 2021 Impact of Dosing Conversion From Basal Insulin to Follow-On Insulin Glargine - Marina L. Maes, Emily J. Ashjian, Kellie A. Kippes, Vince Marshall, Nada Rida, Amy N. Thompson, 2021](https://journals.sagepub.com/cms/10.1177/0897190019853957/asset/images/large/10.1177_0897190019853957-fig1.jpeg)